In the past week, MDXG stock has gone down by -13.10%, with a monthly decline of -1.18% and a quarterly plunge of -8.34%. The volatility ratio for the week is 3.85%, and the volatility levels for the last 30 days are 3.20% for Mimedx Group Inc The simple moving average for the last 20 days is -7.79% for MDXG stock, with a simple moving average of -9.98% for the last 200 days.
Is It Worth Investing in Mimedx Group Inc (NASDAQ: MDXG) Right Now?
Mimedx Group Inc (NASDAQ: MDXG) has a price-to-earnings ratio of 14.43x that is above its average ratio. Additionally, the 36-month beta value for MDXG is 1.98. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MDXG is 115.40M and currently, short sellers hold a 4.38% ratio of that float. The average trading volume of MDXG on August 01, 2024 was 716.96K shares.
MDXG) stock’s latest price update
The stock of Mimedx Group Inc (NASDAQ: MDXG) has decreased by -10.07 when compared to last closing price of 7.45. Despite this, the company has experienced a -13.10% fall in its stock price over the last five trading sessions. seekingalpha.com reported 2024-07-31 that MiMedx Group, Inc. (NASDAQ:MDXG ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Matt Notarianni – Head, Investor Relations Joe Capper – Chief Executive Officer Doug Rice – Chief Financial Officer Conference Call Participants Ross Osborn – Cantor Fitzgerald Chase Knickerbocker – Craig-Hallum Capital Group Brooks O’Neil – Lake Street Capital Markets Anthony Petrone – Mizuho Group Carl Byrnes – Northland Capital Markets Operator Greetings and welcome to the MiMedx Second Quarter 2024 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Analysts’ Opinion of MDXG
Many brokerage firms have already submitted their reports for MDXG stocks, with Cantor Fitzgerald repeating the rating for MDXG by listing it as a “Overweight.” The predicted price for MDXG in the upcoming period, according to Cantor Fitzgerald is $11 based on the research report published on July 02, 2024 of the current year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see MDXG reach a price target of $12. The rating they have provided for MDXG stocks is “Buy” according to the report published on March 07th, 2024.
Craig Hallum gave a rating of “Buy” to MDXG, setting the target price at $12 in the report published on October 27th of the previous year.
MDXG Trading at -6.74% from the 50-Day Moving Average
After a stumble in the market that brought MDXG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.72% of loss for the given period.
Volatility was left at 3.20%, however, over the last 30 days, the volatility rate increased by 3.85%, as shares sank -1.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.13% lower at present.
During the last 5 trading sessions, MDXG fell by -12.97%, which changed the moving average for the period of 200-days by +5.84% in comparison to the 20-day moving average, which settled at $7.26. In addition, Mimedx Group Inc saw -23.60% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDXG starting from Hulse William Frank IV, who sale 20,381 shares at the price of $7.95 back on Mar 13 ’24. After this action, Hulse William Frank IV now owns 479,959 shares of Mimedx Group Inc, valued at $162,029 using the latest closing price.
Whitlow Ricci S, the Chief Operating Officer of Mimedx Group Inc, sale 15,271 shares at $8.01 during a trade that took place back on Feb 20 ’24, which means that Whitlow Ricci S is holding 401,050 shares at $122,351 based on the most recent closing price.
Stock Fundamentals for MDXG
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.83 for the gross margin
The net margin for Mimedx Group Inc stands at 0.28. The total capital return value is set at 0.39. Equity return is now at value 60.87, with 35.95 for asset returns.
Based on Mimedx Group Inc (MDXG), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at 1.45. The debt to equity ratio resting at 0.11. The interest coverage ratio of the stock is 14.98.
Currently, EBITDA for the company is 40.52 million with net debt to EBITDA at -0.68. When we switch over and look at the enterprise to sales, we see a ratio of 2.75. The receivables turnover for the company is 6.45for trailing twelve months and the total asset turnover is 1.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.29.
Conclusion
In conclusion, Mimedx Group Inc (MDXG) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
